SWOG (Formerly the Southwest Oncology Group) is one of the five cooperative groups that together comprise the National Cancer Institute’s (NCI’s) National Clinical Trials Network. SWOG has released the results of a Phase 3 clinical trial that evaluated the impact of combining anti-estrogen drugs to treat post-menopausal women with metastatic breast cancer. The two drugs [...]
Read More...
Archive for the ‘Fulvestrant-Faslodex’ Category
Cancer Research News: Anti-Estrogen Drug Combo Improves Life Expectancy for Post-Menopausal Women with Metastatic Breast Cancer
By juliejoyce on Saturday, December 10th, 2011 | Comments Off
-
-
© 2010-2012 – Dynamic Publishing Co.
Free Digital Photos.net
